Deal to acquire Covis is expected to expand Azurity’s portfolio across multiple complex dosage forms and key therapeutics ...

Covis Pharma, current maker of the preterm birth drug Makena, has withdrawn it from the market after a US Food and Drug Administration (FDA) panel deemed it ineffective. Approved more than a ...

Ryan Churchill, president of Pacific Rim Land Inc., which is managing a project proposed for 53 single-family residential lots on about 28 acres of land neighboring the future $240 million Makena ...